Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Apri Articles

Stock Commentary - New York

21 June 2004

Huge leap in net income at Duramed Pharmaceuticals

24 October 2001

Stock Commentary Europe

5 August 1999

Panic Follows UK's Oral Contraceptive Warning

30 October 1995

FDA APPROVES 26 NEWDRUGS IN 1992

25 January 1993

1992 SEES SMALLER COMPANY MERGERS

4 January 1993

JOHNSON & JOHNSON RECEIVES APPROVAL

21 December 1992

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS